Compare DGII & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | ATRC |
|---|---|---|
| Founded | 1985 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | 2005 |
| Metric | DGII | ATRC |
|---|---|---|
| Price | $47.78 | $32.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $48.80 | ★ $54.50 |
| AVG Volume (30 Days) | 336.4K | ★ 699.4K |
| Earning Date | 02-04-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.55 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | $448,817,000.00 | ★ $518,304,999.00 |
| Revenue This Year | $12.80 | $16.94 |
| Revenue Next Year | $5.47 | $12.54 |
| P/E Ratio | $43.08 | ★ N/A |
| Revenue Growth | 6.40 | ★ 15.80 |
| 52 Week Low | $22.39 | $28.29 |
| 52 Week High | $48.33 | $43.18 |
| Indicator | DGII | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 34.55 |
| Support Level | $44.88 | $30.47 |
| Resistance Level | $47.73 | $38.07 |
| Average True Range (ATR) | 2.41 | 1.67 |
| MACD | 0.31 | -0.56 |
| Stochastic Oscillator | 99.26 | 24.74 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.